Skip to content
DataLookout
Menu

NCT07901634

Association of Inflammatory Biomarkers and Ferritin With Severity of Pediatric Systemic Lupus Erythematosus Patients

StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Pediatric SLE Disease Severity Category
Timeframe: Baseline (at the time of evaluation / sample collection)

Secondary (5)

Systemic Immune-Inflammation Index (SII)
Serum Ferritin Level
Neutrophil-to-Lymphocyte Ratio (NLR)
Platelet-to-Lymphocyte Ratio (PLR)
Numerical SLEDAI-2K Score

Arms and interventions

Pediatric SLE Cohort

Pediatric patients diagnosed with systemic lupus erythematosus (pSLE). All participants undergo clinical and laboratory assessments, including complete blood counts to determine SII, NLR, and PLR, as well as serum ferritin levels. Disease severity is assessed and categorized into mild, moderate, or severe based on the SLEDAI-2K score